Osband M E
Boston City Hospital, Massachusetts.
Hematol Oncol Clin North Am. 1987 Mar;1(1):131-45.
This article focuses on the interaction of histiocytosis-X and the immunotherapeutic agent, suppression. Studies with this and other agents have presented us with invaluable insights into the nature of histiocytosis-X.
本文聚焦于组织细胞增多症-X与免疫治疗药物（抑制作用）之间的相互作用。对该药物及其他药物的研究，让我们对组织细胞增多症-X的本质有了极其宝贵的见解。
